PATHCISION MEDICINE, INC. — Department of Health and Human Services SBIR: SBIR CONCEPT AWARD FOR A NOVEL DELIVERY APPROACH TO TRANSFORM METASTATIC PANCREATIC CANCER
PATHCISION MEDICINE, INC. — SBIR award from Department of Health and Human Services.
SBIR award competitive context
- Public SBIR obligation from Department of Health and Human Services to PATHCISION MEDICINE, INC.. Use agency + tech-domain links below to map the broader competitive field.
- Obligated amount $299,981. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Pathcision Medicine, Inc. was awarded nearly $300,000 by the NIH for an SBIR concept award. The project develops a novel delivery approach to improve treatment and prevention of metastatic pancreatic cancer.
- Amount
- $299,981
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- MA
- Period
- 2025-08-11 → 2027-02-10
Technology domains
Description
SBIR CONCEPT AWARD FOR A NOVEL DELIVERY APPROACH TO TRANSFORM METASTATIC PANCREATIC CANCER TREATMENT AND PREVENTION